Literature DB >> 22023092

Relevance of early detection of HIV type 1 SI/CXCR4-using viruses in vertically infected children.

Cintia M Crudeli1, Paula C Aulicino, Carlos A Rocco, Rosa Bologna, Andrea Mangano, Luisa Sen.   

Abstract

The aim of the study was to investigate the prevalence and persistence of syncytium-inducing (SI) strains in HIV-1-infected children along time of infection and to evaluate the influence of antiretroviral therapy and host factors on viral tropism. This is a retrospective analysis carried out in 267 HIV-1 vertically infected children from an Argentinean cohort. The viral phenotype was screened in MT-2 cells and coreceptor usage confirmed by the GHOST cell assay. Also, CD4(+) T cell count, viral load, antiretroviral therapy, and human CCR5-Δ32 and CCR2-64I genotypes were analyzed. A high frequency of HIV-1 SI/CXCR4-using variants (22%) was found among children within the first trimester of life, reaching 46% after 10 years of infection. At acute infection, zidovudine prophylaxis did not significantly affect the proportions of SI HIV-1 strains, while their presence was favored by the CCR5(+)/Δ32 genotype. Interestingly, the majority of the early SI strains did not persist over time, probably due to a higher susceptibility to antiretroviral (ARV) treatment or immunologic pressure. At the chronic stage, SI variants emerged even in the presence of HAART reaching 36% at 120 months of infection. Also the HIV-1 SI phenotype was associated with lower CD4(+) T cell counts all along the course of infection. These findings highlight the need to evaluate the presence of SI/CXCR4 variants early at primary infection. This will make it possible to optimize the use of CCR5 inhibitors in children who are apparently carriers of the R5 virus preventing early therapeutic failure due to the reemergence of SI strains from reservoirs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22023092      PMCID: PMC3380382          DOI: 10.1089/aid.2011.0111

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  58 in total

1.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

Authors:  B Lee; M Sharron; L J Montaner; D Weissman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.

Authors:  Zabrina L Brumme; James Goodrich; Howard B Mayer; Chanson J Brumme; Bethany M Henrick; Brian Wynhoven; Jerome J Asselin; Peter K Cheung; Robert S Hogg; Julio S G Montaner; P Richard Harrigan
Journal:  J Infect Dis       Date:  2005-06-23       Impact factor: 5.226

3.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

Authors:  A Björndal; H Deng; M Jansson; J R Fiore; C Colognesi; A Karlsson; J Albert; G Scarlatti; D R Littman; E M Fenyö
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  CCR5/delta(ccr5) heterozygosity: a selective pressure for the syncytium-inducing human immunodeficiency virus type 1 phenotype. NIAID AIDS Clinical Trials Group Protocol 241 Virology Team.

Authors:  R T D'Aquila; L Sutton; A Savara; M D Hughes; V A Johnson
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

5.  Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.

Authors:  D E Mosier; G R Picchio; R J Gulizia; R Sabbe; P Poignard; L Picard; R E Offord; D A Thompson; J Wilken
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism.

Authors:  L Zhang; C D Carruthers; T He; Y Huang; Y Cao; G Wang; B Hahn; D D Ho
Journal:  AIDS Res Hum Retroviruses       Date:  1997-11-01       Impact factor: 2.205

7.  Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages.

Authors:  W R Fear; A M Kesson; H Naif; G W Lynch; A L Cunningham
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus.

Authors:  S G Kitchen; J A Zack
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

9.  CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection.

Authors:  H M Naif; S Li; M Alali; A Sloane; L Wu; M Kelly; G Lynch; A Lloyd; A L Cunningham
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

View more
  5 in total

1.  Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.

Authors:  Kristi Huik; Radko Avi; Helen Uibopuu; Merit Pauskar; Tõnu Margus; Tõnis Karki; Tõnu Krispin; Piret Kool; Kristi Rüütel; Ave Talu; Katri Abel-Ollo; Anneli Uusküla; Andrew Carrillo; Weijing He; Sunil K Ahuja; Irja Lutsar
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

2.  Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.

Authors:  Doris G Ransy; Alena Motorina; Natacha Merindol; Bertine S Akouamba; Johanne Samson; Yolanda Lie; Laura A Napolitano; Normand Lapointe; Marc Boucher; Hugo Soudeyns
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

3.  Identification of novel molecular determinants of co-receptor usage in HIV-1 subtype F V3 envelope sequences.

Authors:  Maximiliano Distefano; Esteban Lanzarotti; María Florencia Fernández; Andrea Mangano; Marcelo Martí; Paula Aulicino
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

Review 4.  HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity.

Authors:  Lisa K Smith; Thomas B Kuhn; Jack Chen; James R Bamburg
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

5.  Association of X4 tropism with disease progression in antiretroviral-treated children and adolescents living with HIV/AIDS in São Paulo, Brazil.

Authors:  Flávia Jacqueline Almeida; Mayra Simioni Zaparoli; Denise Helena Moreira; Jaqueline de Souza Cavalcanti; Rosangela Rodrigues; Eitan Naaman Berezin; João Leandro de Paula Ferreira; Marco Aurélio Palazzi Sáfadi; Luis Fernando de Macedo Brígido
Journal:  Braz J Infect Dis       Date:  2013-11-22       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.